查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534397

心臟再同步治疗 (CRT) 设备市场：全球市场规模、份额、趋势分析、机会、预测报告，2019-2030 年

Cardiac Resynchronization Therapy Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type; By Age; By End Use; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

心臟再同步治疗 (CRT) 设备的全球市场规模正以 8.4% 的复合年增长率快速增长，到 2030 年将达到 116 亿美元

由于心臟衰竭的流行、设备技术的进步、人口老化和意识的提高，全球心臟再同步治疗 (CRT) 设备的使用量不断增加，因此全球心臟再同步治疗 (CRT) 设备市场正在不断增长。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计， 以金额为准65.9 亿美元。 BlueWeave 预测，在 2024 年至 2030 年的预测期内，心臟再同步治疗 (CRT) 设备的全球市场规模将以 8.4% 的复合年增长率增长，到 2030 年达到 115.9 亿美元。心臟衰竭和心臟疾病负担日益增加、人口老化和久坐的生活方式推动了心臟再同步治疗 (CRT) 设备的全球市场。世界人口正在迅速老化，导致出生率下降和预期寿命延长。由于人口老化，心血管疾病和心臟衰竭的增加将增加对 CRT 的需求，并在分析期间推动市场成长。

机会 - 在医疗保健领域更多地采用巨量资料

随着主要医疗保健公司采取积极措施，心臟再同步治疗 (CRT) 设备的全球市场正在蓬勃发展。这些措施包括加速产品开发、市场开拓和改善患者治疗效果。领先公司专注于先进技术，为心臟病患者开发突破性产品。我们也与医疗保健提供者和学术机构合作进行临床研究。这些公司正在透过策略联盟和行销努力扩大其市场份额，以改善全球患者对 CRT 设备的使用并推动市场成长。

地缘政治紧张局势加剧对全球心臟再同步治疗 (CRT) 设备市场的影响

地区之间不断升级的地缘政治紧张局势正在扰乱供应链、影响关键技术的贸易限制、外汇不稳定导致的成本增加、研发投资不确定性导致的创新放缓，以及破坏医疗基础设施，这将影响全球心臟再同步治疗(CRT) 设备市场。

心臟再同步治疗 (CRT) 设备的全球市场

按细分市场分類的覆盖范围

心臟再同步治疗 (CRT) 设备的全球市场 – 依产品类型

依产品类型划分，全球心臟再同步治疗 (CRT) 设备市场分为 CRT心律调节器和 CRT心臟去颤器(CRT-D)。 CRT-D 设备在市场上占据主导地位。 CRT-D 设备可同步心律并提供去心房颤动电击。 CRT-D具有双重功能，是高风险患者的首选。技术进步（例如电池寿命的延长）正在推动广泛采用。儘管 CRT-D 设备昂贵且复杂，但它拥有很大的市场占有率，因为它们在严重的心臟疾病中发挥着重要作用。

心臟再同步治疗 (CRT) 设备的全球市场 - 按年龄

依年龄划分，全球心臟再同步治疗 (CRT) 设备市场分为 44 岁及以下、45-64 岁、65-84 岁及 85 岁以上。 65 岁至 84 岁之间的人群主导着全球 CRT 机市场，因为他们患有与心臟相关的疾病最多。已开发国家人口老化，心血管疾病往往随着老龄化的增长而增加。这个年龄层的人获得医疗保健的机会促进了 CRT 设备的普及，影响了市场动态，并鼓励製造商专注于为老年患者量身定制的创新。

竞争格局

全球心臟再同步治疗（CRT）设备市场竞争激烈。市场主要企业包括美敦力、雅培、波士顿科学公司、百多力、微创科学公司、Livanova plc、Integer Holdings Corporation、乐普医疗科技有限公司、梅奥诊所、Osypka Medical等。这些公司正在增加对研发活动、併购、收购、合资、联盟、授权合约、新产品的投资，并采用各种策略，包括服务发布。

该报告的详细分析提供了有关全球心臟再同步治疗（CRT）设备市场的成长潜力、未来趋势和统计数据的资讯。我们也关注推动市场总规模预测的因素。该报告致力于提供全球心臟再同步治疗 (CRT) 设备市场的最新技术趋势和产业见解，以帮助决策者做出适当的策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第 3 章心臟再同步治疗 (CRT) 设备的全球市场洞察

  • 最终用途价值链分析
  • DROC分析
    • 生长促进因子
      • 心血管疾病发生率上升
      • 人口老化加剧
      • 产品技术进步
      • 发展中地区医疗基础设施的扩大和良好的财务状况
    • 抑制因素
      • CRT设备和植入手术的高成本
      • 严格监管场景
      • 病患和医疗专业人员对 CRT 的益处缺乏认识
    • 机会
      • 更多采用新技术
      • 主要公司的措施增加
      • 增加微创手术的引入
    • 任务
      • 装置植入的复杂性
      • 与替代疗法的竞争
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章全球心臟再同步治疗（CRT）设备市场：行销策略

第五章全球心臟再同步治疗（CRT）设备市场：价格分析

第六章全球心臟再同步治疗 (CRT) 设备市场：区域分析

  • 全球心臟再同步治疗 (CRT) 设备市场，区域分析，2023 年
  • 2024-2030 年全球心臟再同步治疗 (CRT) 设备市场吸引力分析

第七章全球心臟再同步治疗（CRT）设备市场概述

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
      • CRT心律心律调节器
      • CRT心臟去颤器
    • 按年龄
      • 44岁以下
      • 45-64岁
      • 65-84岁
      • 85岁以上
    • 按最终用途
      • 医院
      • 心臟护理中心
      • 门诊手术中心
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲（中东/非洲）

第八章北美心臟再同步治疗（CRT）设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
    • 按年龄
    • 按最终用途
    • 按国家/地区
      • 美国
      • 加拿大

第九章欧洲心臟再同步治疗（CRT）设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
    • 按年龄
    • 按最终用途
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第十章亚太心臟再同步治疗（CRT）设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
    • 按年龄
    • 按最终用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第十一章拉丁美洲心臟再同步治疗（CRT）设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
    • 按年龄
    • 按最终用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十二章中东与非洲心臟再同步治疗（CRT）设备市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依产品类型
    • 按年龄
    • 按最终用途
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 中东和非洲其他地区

第十三章竞争格局

  • 主要企业及其产品列表
  • 2023年心臟再同步治疗（CRT）设备公司全球市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 重大策略发展（合併、收购、联盟等）

第14章 地缘政治紧张局势加剧对全球心臟再同步治疗（CRT）设备市场的影响

第十五章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Biotronik
  • MicroPort Scientific Corporation
  • Livanova plc
  • Integer Holdings Corporation
  • Lepu Medical Technology Co Ltd
  • Mayo Clinic
  • Osypka Medical
  • 其他主要企业

第十六章 主要策略建议

第十七章调查方法

简介目录
Product Code: BWC24471

Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030

Global Cardiac Resynchronization Therapy (CRT) Devices Market is growing due to heart failure prevalence, device tech advances, aging population, and increased awareness, boosting CRT device usage worldwide.

BlueWeave Consulting, a leading strategic consulting, and Market research firm, in its recent study, estimated the Global Cardiac Resynchronization Therapy (CRT) Devices Market size by value at USD 6.59 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cardiac Resynchronization Therapy (CRT) Devices Market size to expand at a CAGR of 8.4% reaching a value of USD 11.59 billion in 2030. The Global Cardiac Resynchronization Therapy (CRT) Devices Market is driven by the increasing burden of heart failure and cardiac disorders, the geriatric population, and the sedentary lifestyle. The global population is aging rapidly, leading to reduced birth rates and increased life expectancy. The geriatric population's rise in cardiovascular and heart failure cases increases the demand for CRT, boosting market growth during the period in analysis.

Opportunity - Growing adoption of Big Data in healthcare

The Global Market for Cardiac Resynchronization Therapy (CRT) Devices is prospering as a result of proactive measures incorporated by major healthcare businesses. These measures include accelerating product development, broadening market reach, and improving patient outcomes. Major corporations are focused on sophisticated technologies to develop breakthrough goods for cardiac patients. They also work with healthcare providers and academic organizations on clinical research. These firms are extending their market presence through strategic collaborations and marketing activities, to improve global patient access to CRT devices and drive market growth.

Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

Intensifying geopolitical tensions across regions impact the Global Cardiac Resynchronization Therapy (CRT) Devices Market through supply chain disruptions, trade restrictions affecting essential technologies, increased costs due to unstable currency exchange rates, slowed innovation from uncertain R&D investments, and reduced market size in regions with unstable healthcare infrastructure.

Global Cardiac Resynchronization Therapy (CRT) Devices Market

Segmental Coverage

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Product Type

Based on product type, Global Cardiac Resynchronization Therapy (CRT) Devices Market is split into CRT-Pacemakers and CRT-Defibrillators segments. CRT-D devices dominate the market. CRT-D devices synchronize heart rhythm and provide life-saving defibrillation shocks. Their dual functionality is preferred for high risk patients. Advancements in technology like improved battery life increase adoption. CRT-D devices, despite being costly and complex, have a larger market share due to their critical role in severe cardiac conditions.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Age

Based on age, the Global Cardiac Resynchronization Therapy (CRT) Devices Market is divided into Below 44 years, 45-64 years, 65-84 years, and Above 85 years segments. The 65-84 age group dominates the Global CRT Devices Market due to its high heart-related conditions. Aging populations in developed countries drive this trend as cardiovascular issues rise with age. This group's access to healthcare contributes to CRT device adoption, influencing market dynamics and prompting manufacturers to focus on tailored innovations for older patients.

Competitive Landscape

The Global Cardiac Resynchronization Therapy (CRT) Devices Market is fiercely competitive. Major companies in the market include Medtronic, Abbott, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, Livanova plc, Integer Holdings Corporation, Lepu Medical Technology Co., Ltd, Mayo Clinic, and Osypka Medical. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Cardiac Resynchronization Therapy (CRT) Devices Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Cardiac Resynchronization Therapy (CRT) Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Cardiac Resynchronization Therapy (CRT) Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Cardiac Resynchronization Therapy (CRT) Devices Market Insights

  • 3.1. End Use Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising incidence of cardiovascular disorders
      • 3.2.1.2. Growing geriatric population
      • 3.2.1.3. Increasing advancements in product technology
      • 3.2.1.4. Expanding medical infrastructure and favorable financial conditions in developing regions
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of CRT devices and implantation procedures
      • 3.2.2.2. Stringent regulatory scenario
      • 3.2.2.3. Lack of awareness among patients and healthcare providers about the benefits of CRT
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing adoption of new technology
      • 3.2.3.2. Rising initiatives by major companies
      • 3.2.3.3. Increasing adoption of minimally invasive procedures
    • 3.2.4. Challenges
      • 3.2.4.1. Complexity of device implantation
      • 3.2.4.2. Competition from alternative therapies
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Marketing Strategies

5. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Pricing Analysis

6. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Geography Analysis

  • 6.1. Global Cardiac Resynchronization Therapy (CRT) Devices Market, Geographical Analysis, 2023
  • 6.2. Global Cardiac Resynchronization Therapy (CRT) Devices, Market Attractiveness Analysis, 2024-2030

7. Global Cardiac Resynchronization Therapy (CRT) Devices Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
      • 7.2.1.1. CRT-Pacemakers
      • 7.2.1.2. CRT-Defibrillators
    • 7.2.2. By Age
      • 7.2.2.1. Below 44 years
      • 7.2.2.2. 45-64 years
      • 7.2.2.3. 65-84 years
      • 7.2.2.4. Above 85 years
    • 7.2.3. By End Use
      • 7.2.3.1. Hospitals
      • 7.2.3.2. Cardiac care centers
      • 7.2.3.3. Ambulatory surgical centers
      • 7.2.3.4. Others
    • 7.2.4. By Region
      • 7.2.4.1. North America
      • 7.2.4.2. Europe
      • 7.2.4.3. Asia Pacific (APAC)
      • 7.2.4.4. Latin America (LATAM)
      • 7.2.4.5. Middle East and Africa (MEA)

8. North America Cardiac Resynchronization Therapy (CRT) Devices Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Age
    • 8.2.3. By End Use
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.1.1. By Product Type
      • 8.2.4.1.2. By Age
      • 8.2.4.1.3. By End Use
      • 8.2.4.2. Canada
      • 8.2.4.2.1. By Product Type
      • 8.2.4.2.2. By Age
      • 8.2.4.2.3. By End Use

9. Europe Cardiac Resynchronization Therapy (CRT) Devices Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Age
    • 9.2.3. By End Use
    • 9.2.4. By Country
      • 9.2.4.1. Germany
      • 9.2.4.1.1. By Product Type
      • 9.2.4.1.2. By Age
      • 9.2.4.1.3. By End Use
      • 9.2.4.2. United Kingdom
      • 9.2.4.2.1. By Product Type
      • 9.2.4.2.2. By Age
      • 9.2.4.2.3. By End Use
      • 9.2.4.3. Italy
      • 9.2.4.3.1. By Product Type
      • 9.2.4.3.2. By Age
      • 9.2.4.3.3. By End Use
      • 9.2.4.4. France
      • 9.2.4.4.1. By Product Type
      • 9.2.4.4.2. By Age
      • 9.2.4.4.3. By End Use
      • 9.2.4.5. Spain
      • 9.2.4.5.1. By Product Type
      • 9.2.4.5.2. By Age
      • 9.2.4.5.3. By End Use
      • 9.2.4.6. Belgium
      • 9.2.4.6.1. By Product Type
      • 9.2.4.6.2. By Age
      • 9.2.4.6.3. By End Use
      • 9.2.4.7. Russia
      • 9.2.4.7.1. By Product Type
      • 9.2.4.7.2. By Age
      • 9.2.4.7.3. By End Use
      • 9.2.4.8. The Netherlands
      • 9.2.4.8.1. By Product Type
      • 9.2.4.8.2. By Age
      • 9.2.4.8.3. By End Use
      • 9.2.4.9. Rest of Europe
      • 9.2.4.9.1. By Product Type
      • 9.2.4.9.2. By Age
      • 9.2.4.9.3. By End Use

10. Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Age
    • 10.2.3. By End Use
    • 10.2.4. By Country
      • 10.2.4.1. China
      • 10.2.4.1.1. By Product Type
      • 10.2.4.1.2. By Age
      • 10.2.4.1.3. By End Use
      • 10.2.4.2. India
      • 10.2.4.2.1. By Product Type
      • 10.2.4.2.2. By Age
      • 10.2.4.2.3. By End Use
      • 10.2.4.3. Japan
      • 10.2.4.3.1. By Product Type
      • 10.2.4.3.2. By Age
      • 10.2.4.3.3. By End Use
      • 10.2.4.4. South Korea
      • 10.2.4.4.1. By Product Type
      • 10.2.4.4.2. By Age
      • 10.2.4.4.3. By End Use
      • 10.2.4.5. Australia & New Zealand
      • 10.2.4.5.1. By Product Type
      • 10.2.4.5.2. By Age
      • 10.2.4.5.3. By End Use
      • 10.2.4.6. Indonesia
      • 10.2.4.6.1. By Product Type
      • 10.2.4.6.2. By Age
      • 10.2.4.6.3. By End Use
      • 10.2.4.7. Malaysia
      • 10.2.4.7.1. By Product Type
      • 10.2.4.7.2. By Age
      • 10.2.4.7.3. By End Use
      • 10.2.4.8. Singapore
      • 10.2.4.8.1. By Product Type
      • 10.2.4.8.2. By Age
      • 10.2.4.8.3. By End Use
      • 10.2.4.9. Vietnam
      • 10.2.4.9.1. By Product Type
      • 10.2.4.9.2. By Age
      • 10.2.4.9.3. By End Use
      • 10.2.4.10. Rest of APAC
      • 10.2.4.10.1. By Product Type
      • 10.2.4.10.2. By Age
      • 10.2.4.10.3. By End Use

11. Latin America Cardiac Resynchronization Therapy (CRT) Devices Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Age
    • 11.2.3. By End Use
    • 11.2.4. By Country
      • 11.2.4.1. Brazil
      • 11.2.4.1.1. By Product Type
      • 11.2.4.1.2. By Age
      • 11.2.4.1.3. By End Use
      • 11.2.4.2. Mexico
      • 11.2.4.2.1. By Product Type
      • 11.2.4.2.2. By Age
      • 11.2.4.2.3. By End Use
      • 11.2.4.3. Argentina
      • 11.2.4.3.1. By Product Type
      • 11.2.4.3.2. By Age
      • 11.2.4.3.3. By End Use
      • 11.2.4.4. Peru
      • 11.2.4.4.1. By Product Type
      • 11.2.4.4.2. By Age
      • 11.2.4.4.3. By End Use
      • 11.2.4.5. Rest of LATAM
      • 11.2.4.5.1. By Product Type
      • 11.2.4.5.2. By Age
      • 11.2.4.5.3. By End Use

12. Middle East & Africa Cardiac Resynchronization Therapy (CRT) Devices Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product Type
    • 12.2.2. By Age
    • 12.2.3. By End Use
    • 12.2.4. By Country
      • 12.2.4.1. Saudi Arabia
      • 12.2.4.1.1. By Product Type
      • 12.2.4.1.2. By Age
      • 12.2.4.1.3. By End Use
      • 12.2.4.2. UAE
      • 12.2.4.2.1. By Product Type
      • 12.2.4.2.2. By Age
      • 12.2.4.2.3. By End Use
      • 12.2.4.3. Qatar
      • 12.2.4.3.1. By Product Type
      • 12.2.4.3.2. By Age
      • 12.2.4.3.3. By End Use
      • 12.2.4.4. Kuwait
      • 12.2.4.4.1. By Product Type
      • 12.2.4.4.2. By Age
      • 12.2.4.4.3. By End Use
      • 12.2.4.5. South Africa
      • 12.2.4.5.1. By Product Type
      • 12.2.4.5.2. By Age
      • 12.2.4.5.3. By End Use
      • 12.2.4.6. Nigeria
      • 12.2.4.6.1. By Product Type
      • 12.2.4.6.2. By Age
      • 12.2.4.6.3. By End Use
      • 12.2.4.7. Algeria
      • 12.2.4.7.1. By Product Type
      • 12.2.4.7.2. By Age
      • 12.2.4.7.3. By End Use
      • 12.2.4.8. Rest of MEA
      • 12.2.4.8.1. By Product Type
      • 12.2.4.8.2. By Age
      • 12.2.4.8.3. By End Use

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Cardiac Resynchronization Therapy (CRT) Devices Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Medtronic
  • 15.2. Abbott
  • 15.3. Boston Scientific Corporation
  • 15.4. Biotronik
  • 15.5. MicroPort Scientific Corporation
  • 15.6. Livanova plc
  • 15.7. Integer Holdings Corporation
  • 15.8. Lepu Medical Technology Co Ltd
  • 15.9. Mayo Clinic
  • 15.10. Osypka Medical
  • 15.11. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable